vcreate: T-cell Receptor Engineering Platform
vcreate supports biotechnology and pharmaceutical companies in designing T-cell receptor (TCR) based therapies. It is designed for research teams that need to screen high volumes of TCR-antigen interactions.
At a glance
- Category
- Healthcare
- Best for
- Biotechnology companies, Pharmaceutical companies, Research labs
- Pricing
- Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
- Key use cases
- TCR-Based Drug Discovery, Cancer Mutation Targeting, Lead Identification
- Official website
- vcreate.io
vcreate is a biotechnology platform designed to engineer human T-cell receptors (TCRs) for treating diseases, specifically focusing on cancer. The platform uses machine learning and molecular biology to identify TCRs that target disease-specific mutations, including those that are difficult to address with conventional therapies.
The tool is intended for use by biotechnology companies, pharmaceutical firms, and research laboratories. By using single-cell sequencing, the platform can screen hundreds of millions of interactions in a single experiment, which is designed to support faster discovery compared to traditional methods like yeast display or tetramer staining.
Buyers should note that the platform focuses specifically on TCR-based drug design. Interested parties should contact the company directly to discuss collaboration or co-development options.
Key Features
Algorithms trained on datasets to design T-cell receptors that activate against specific targets of interest.
Screening assays that can interrogate hundreds of millions of TCR-antigen interactions in a single flask.
Use of single-cell sequencing to support the identification of TCRs for disease-specific targets.
Designed to target rare cancer mutations even when they are not present in experimental datasets.
Use Cases
Designing high-precision T-cell receptors intended to destroy target cells while sparing normal cells.
Identifying TCRs that can guide the immune system to eliminate cells carrying specific mutated genes.
Using high-speed screening to identify receptors that activate against disease targets.
Best For
Pricing
Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.
FAQ
vcreate uses machine learning and molecular biology to design and engineer human T-cell receptors (TCRs) used in the treatment of diseases such as cancer.
The platform is designed for biotechnology companies, pharmaceutical companies, and research laboratories focusing on TCR-based therapies.
By using single-cell sequencing and novel assays, the platform can screen hundreds of millions of TCR-antigen interactions in a single experiment.
Source category: Healthcare
Source subcategory: Biotechnology Platform
